DYN
Price
$11.11
Change
+$0.33 (+3.06%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.26B
6 days until earnings call
IOBT
Price
$0.93
Change
-$0.01 (-1.06%)
Updated
Apr 24, 04:58 PM (EDT)
Capitalization
60.79M
24 days until earnings call
Ad is loading...

DYN vs IOBT

Header iconDYN vs IOBT Comparison
Open Charts DYN vs IOBTBanner chart's image
Dyne Therapeutics
Price$11.11
Change+$0.33 (+3.06%)
Volume$39.79K
Capitalization1.26B
IO Biotech
Price$0.93
Change-$0.01 (-1.06%)
Volume$200
Capitalization60.79M
DYN vs IOBT Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. IOBT commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Buy and IOBT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (DYN: $11.11 vs. IOBT: $0.94)
Brand notoriety: DYN and IOBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 89% vs. IOBT: 47%
Market capitalization -- DYN: $1.26B vs. IOBT: $61.93M
DYN [@Biotechnology] is valued at $1.26B. IOBT’s [@Biotechnology] market capitalization is $61.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileIOBT’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • IOBT’s FA Score: 1 green, 4 red.
According to our system of comparison, IOBT is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while IOBT’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 4 bearish.
  • IOBT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DYN is a better buy in the short-term than IOBT.

Price Growth

DYN (@Biotechnology) experienced а +35.99% price change this week, while IOBT (@Biotechnology) price change was +5.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

IOBT is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.26B) has a higher market cap than IOBT($60.8M). IOBT YTD gains are higher at: 0.304 vs. DYN (-54.244). IOBT has higher annual earnings (EBITDA): -89.37M vs. DYN (-342.21M). DYN has more cash in the bank: 642M vs. IOBT (80.2M). IOBT has less debt than DYN: IOBT (2.02M) vs DYN (24M). DYN (0) and IOBT (0) have equivalent revenues.
DYNIOBTDYN / IOBT
Capitalization1.26B60.8M2,076%
EBITDA-342.21M-89.37M383%
Gain YTD-54.2440.304-17,823%
P/E RatioN/AN/A-
Revenue00-
Total Cash642M80.2M800%
Total Debt24M2.02M1,189%
TECHNICAL ANALYSIS
Technical Analysis
DYNIOBT
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WAL70.802.10
+3.06%
Western Alliance Bancorporation
PDD103.272.84
+2.83%
PDD Holdings
ACRE3.820.05
+1.33%
Ares Commercial Real Estate Corp
GETY1.850.01
+0.54%
Getty Images Holdings
MCHX1.42-0.02
-1.39%
Marchex

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+8.78%
CRNX - DYN
50%
Loosely correlated
+3.55%
ROIV - DYN
48%
Loosely correlated
+2.98%
INZY - DYN
47%
Loosely correlated
-4.84%
RNA - DYN
47%
Loosely correlated
+4.18%
ERAS - DYN
47%
Loosely correlated
+2.90%
More

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with GLMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
-1.83%
GLMD - IOBT
36%
Loosely correlated
-0.61%
DYN - IOBT
34%
Loosely correlated
+3.06%
RCKT - IOBT
34%
Loosely correlated
+4.06%
IOVA - IOBT
33%
Loosely correlated
+5.33%
RXRX - IOBT
32%
Poorly correlated
+3.05%
More